News

Filter

Topic: Neurology Department

July 8, 2020
Experimental drug shows early promise against inherited form of ALS, trial indicates
Phase 1/phase 2 trial shows evidence for safety, biological activity of tofersen; phase 3 trial underway.
News Release
June 16, 2020
Previously undetected brain pulses may help circuits survive disuse, injury
Research may lead to treatment advances for patients with immobilizing illness, injury.
News Release
June 4, 2020
$3.7 million aimed at studying effect of manganese exposure on cognitive skills
Study of welders could shine light on early stages of Parkinson’s disease.
News Release
May 4, 2020
Gutmann receives Advocate of Hope award
Honored for dedication to finding causes, treatments for common genetic disease.
National Leaders
May 1, 2020
New targets for childhood brain tumors identified
Neurons, immune cells work together to promote tumor growth in neurofibromatosis type 1.
News Release
April 10, 2020
Anne Cross working to change face of multiple sclerosis care
Researcher made it her life’s work to study and treat patients with MS.
Outlook Magazine
March 26, 2020
Insight into Alzheimer’s early stages provides clues to treatment strategies
Tau protein changes years before cognitive symptoms.
News Release
March 6, 2020
Washington University to break ground on major neuroscience research hub
New construction will inspire discovery, collaboration, faculty recruitment at School of Medicine.
News Release, Video
February 25, 2020
Washington People: Kathy Kniepmann
Inquisitive, compassionate occupational therapy associate professor inspires prospective, current students.
Washington People
February 10, 2020
Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates
Top-line data reported from international trial.
News Release
February 5, 2020
Gene ID’d as potential therapeutic target for dementia in Parkinson’s
Targeting gene linked to Alzheimer’s may reduce dementia risk in Parkinson’s.
News Release
January 16, 2020
$29 million for new phase of international Alzheimer’s study
Research focuses on precisely how the disease develops in the brain.
News Release
January 6, 2020
Miller receives international innovation prize
Recognized for developing experimental treatment for ALS.
National Leaders
December 17, 2019
Hogan elected officer of American Epilepsy Society
Expert on neuroimaging, pharmacological treatment of epilepsy.
National Leaders
December 10, 2019
Why doesn’t deep-brain stimulation work for everyone?
Personalized brain maps could improve treatment for Parkinson's disease, other neurological conditions.
News Release
November 19, 2019
Major Alzheimer’s study to open 5 new Latin American sites
Expansion will shed light on Alzheimer’s disease in Latino populations.
News Release
November 19, 2019
Importante estudio en enfermedad de Alzheimer abrirá 5 nuevos sitios latinoamericanos
Los nuevos sitios aportarán relevantes datos sobre la enfermedad de Alzheimer en las poblaciones latinas.
November 13, 2019
Kipnis named BJC Investigator
Leader in groundbreaking research on interaction of brain and immune system to join faculty.
News Release
October 22, 2019
Dementia patients’ adult kids diagnosed earlier than their parents
Unknown genetic factors may affect when symptoms arise.
News Release
October 10, 2019
Targeting immune cells may be potential therapy for Alzheimer’s
Mouse study shows immune cells drive brain damage.
News Release, Video
October 4, 2019
Alzheimer’s research reset
Source: Science Magazine
October 1, 2019
Gutmann wins prestigious neuro-oncology prize
Honored for work on pediatric brain tumors.
National Leaders
September 27, 2019
Holtzman awarded Watanabe Prize in Translational Research
Recognized for developing potential therapies for Alzheimer’s disease.
National Leaders
August 15, 2019
Antisense drugs for Huntington’s, ALS and prion diseases could meet the dire need for brain treatments
Source: Scientific American